Improving DVT Prevention, Detection and Treatment in High-Risk Specialties
A three part series that will focus on the five groups of patients at particularly high risk of developing venous thromboembolic (VTE) disease: Cardiology, Orthopedic, Obstetrics/Gynecologic, Neurology and Oncology patients.
To view the webcast or to print the program materials please click on the program titles below for each broadcast page.
Part I: Strategies to improve DVT prophylaxis, early identification, treatment and post discharge follow-up in Cardiology and Orthopedic patients
Release Date: September 9, 2008
Re-Broadcast: September 17 & 25, 2008
Termination Date: September 8, 2010
Media Available: Satellite, Webcast, DVD & VHS
Time to Complete the Activity: 1 Hour 30 Minutes
Medical Moderator:
Joseph S. Prosser, MD, MBA, CPE, FACPE
Vice President, Chief Quality Officer
Harris Methodist Fort Worth Hospital
Fort Worth, Texas
Faculty:
Cardiology
Samuel Z. Goldhaber, MD
Professor of Medicine
Harvard Medical School
Brigham and Women's Hospital
Boston, Massachusetts
Orthopedics
Andrew F. Shorr, MD, MPH
Associate Professor of Medicine
Department of Pulmonary and Critical Care Medicine
George Washington University
Washington, DC
Part II: Strategies to improve DVT prophylaxis, early identification, treatment and post discharge follow-up in OB/GYN and Neurology patients
Release Date: September 10, 2008
Re-Broadcast: September 18 & 24, 2008
Termination Date: September 9, 2010
Media Available: Satellite, Webcast, DVD & VHS
Time to Complete the Activity: 1 Hour 30 Minutes
Medical Moderator:
William A. Brock, MD, FCCM, FCCP, FACP
Vice President, Chief Quality Officer
Presbyterian Hospital of Plano
Plano, Texas
Faculty:
Neurology
Joseph A. Caprini, MD, MS, FACS
Professor, Department of Surgery
Feinberg School of Medicine
Northwestern University
Chicago, Illinois
Gynecology
Thomas C. Krivak, MD
Assistant Professor, Department of Obstetrics
Gynecology and Reproductive Sciences Division of Gynecology Oncology
University of Pittsburgh Medical Center
UPMC Cancer Center at Magee-Womens Hospital
Pittsburgh, Pennsylvania
Part III: Strategies to improve DVT prophylaxis, early identification, treatment and post discharge follow-up in hospitalized and ambulatory Oncology patients
Release Date: October 21, 2008
Re-Broadcast: October 23 & 28, 2008
Termination Date: October 20, 2010
Media Available: Satellite, Webcast, DVD & VHS
Time to Complete the Activity: 1 Hour 30 Minutes
Medical Moderator:
Jaya V. Juturi, MD
Chief Medical Officer, NexGen Oncology
Chief, Hematology/Oncology
Presbyterian Hospital of Dallas
Dallas, Texas
Faculty:
Carmen Escalante, MD
Professor and Chair
Department of General Internal Medicine
Ambulatory Treatment and Emergency Care
UT MD Anderson Cancer Center
Houston, Texas
Kristin K. Zorn, MD
Magee-Womens Hospital of UPMC
Division of Gynecologic Oncology
Pittsburgh, Pennsylvania
If your organization is interested in participating in an outcomes research study around DVT please contact Professional Education at 866-865-5448.
ACCREDITATION
PHYSICIAN
The Research and Education Institute for Texas Health Resources is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Research and Education Institute for Texas Health Resources designates this educational activity for a maximum of 1.5 (for each session) AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
NURSING
Presbyterian Hospital of Plano, Education Department, has approved this program for 1.5 contact hours for each session. This program has been approved by the American Association of Critical-Care Nurses (AACN).
This series is being provided by The Research and Education Institute for Texas Health Resources, courtesy of an educational grant from GlaxoSmithKline and sanofi-aventis U.S.
The opinions expressed in this program are those of the speaker and do not necessarily reflect the opinions or recommendations of the speaker's affiliated institutions, the publisher, The Research and Education Institute for Texas Health Resources (the accreditor), GlaxoSmithKline & sanofi-aventis U.S. (the commercial supporter), or CRM Healthcare. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients’ conditions and possible contraindications or risks or without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.
|
